Darus Salaam Pharmaceuticals (Opc) Private Limited - Company Profile

It is a chemicals enterprise based in Kolkata, West Bengal, India, established in 2018.
2018 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Darus Salaam Pharmaceuticals (Opc) Private Limited

Darus Salaam Pharmaceuticals (Opc) Private Limited, Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299WB2018OPC229119. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Faheem Ellahi Khan (Director). Its latest balance sheet filed on 31 March 2019. It is based at 28/1/A Sir Syed Ahmed Road, Kolkata, West Bengal, 700014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299WB2018OPC229119

  • Registration Number

    229119

  • Incorporation Date

    05 December 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 2 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Darus Salaam Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Darus Salaam Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Darus Salaam Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Faheem Ellahi Khan Director 05 Dec 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Darus Salaam Pharmaceuticals (Opc).

Enhance accessibility to Darus Salaam Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Darus Salaam Pharmaceuticals (Opc) revenue growth over time
Darus Salaam Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Darus Salaam Pharmaceuticals (Opc)?

Unlock access to Darus Salaam Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Darus Salaam Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Darus Salaam Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Darus Salaam Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darus Salaam Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Darus Salaam Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Balance Sheet

    The activity Darus Salaam Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kolkata. was completed.

  • Director Appointment

    Faheem Ellahi Khan was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.

  • Company Incorporation

    Darus Salaam Pharmaceuticals (Opc) Private Limited was registered on 05 Dec 2018 with Roc Kolkata & aged 7 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Darus Salaam Pharmaceuticals (Opc) Private Limited?

The CIN of Darus Salaam Pharmaceuticals (Opc) Private Limited is U24299WB2018OPC229119.

Where is Darus Salaam Pharmaceuticals (Opc) Private Limited headquartered?

Darus Salaam Pharmaceuticals (Opc) Private Limited is headquartered at 28/1/A Sir Syed Ahmed Road, Kolkata, West Bengal, 700014.

When was Darus Salaam Pharmaceuticals (Opc) Private Limited incorporated?

Darus Salaam Pharmaceuticals (Opc) Private Limited was incorporated on 05 December 2018.

Who are the current directors of Darus Salaam Pharmaceuticals (Opc) Private Limited?

The current directors of Darus Salaam Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Darus Salaam Pharmaceuticals (Opc) Private Limited?

The primary industry of Darus Salaam Pharmaceuticals (Opc) Private Limited is Chemicals.

Is Darus Salaam Pharmaceuticals (Opc) Private Limited a listed company?

Darus Salaam Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Darus Salaam Pharmaceuticals (Opc) Private Limited?

The authorized capital of Darus Salaam Pharmaceuticals (Opc) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available